Silencing RRM2 inhibits multiple myeloma by targeting the Wnt/β-catenin signaling pathway

被引:22
|
作者
Liu, Xia [1 ]
Peng, Jiamin [2 ]
Zhou, Yayun [2 ]
Xie, Bei [2 ]
Wang, Jianchao [3 ]
机构
[1] Zhejiang Chinese Med Univ, Affiliated Hosp 2, Cent Lab, 318 C haowang Rd, Hangzhou 310005, Zhejiang, Peoples R China
[2] Zhejiang Chinese Med Univ, Clin Med Coll 2, Hangzhou 310005, Zhejiang, Peoples R China
[3] Zhejiang Tongde Hosp Zhejiang Prov, Dept Clin Lab, 234 Gucui Rd, Hangzhou 310012, Zhejiang, Peoples R China
关键词
multiple myeloma; ribonucleotide reductase M2; DNA damage; apoptosis; Wnt/beta-catenin signaling; RIBONUCLEOTIDE REDUCTASE M2; THERAPEUTIC TARGET; RNA INTERFERENCE; CANCER; SUBUNIT; EXPRESSION; CELLS; SUPPRESSION; APOPTOSIS; PROMOTES;
D O I
10.3892/mmr.2019.10465
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ribonucleotide reductase M2 (RRM2) is one of the two subunits that comprise ribonucleotide reductase (RR), the enzyme that catalyzes the conversion of ribonucleotide 5'-diphosphates into 2'-deoxyribonucleotides, which are required for DNA synthesis. RRM2 is a stress response factor important for the development of several tumors. However, its role in multiple myeloma (MM) remains to be fully elucidated. The present study aimed to investigate the role of RRM2 in MM. The expression of RRM2 in patients with MM was analyzed using the Oncomine database. The results demonstrated that RRM2 expression was higher in MM compared with healthy subjects. Reverse transcription-quantitative polymerase chain reaction and western blot results revealed that RRM2 expression was decreased following transfection with a small interfering RNA targeting RRM2 into NCI-H929 cells. RR activity and Cell Counting Kit-8 assays demonstrated that RRM2 silencing reduced RR activity and inhibited cell proliferation. Annexin V-propidium iodide staining indicated that the percentage of apoptotic NCI-H929 cells was increased following RRM2 silencing compared with that in the control group. Increased phosphorylation of H2AX indicated that RRM2 silencing may activate the DNA-damage response pathway in NCI-H929 cells. Western blot analysis revealed that protein levels of the apoptosis-associated factor Bcl-2 were reduced, whereas Bax, cleaved caspase-3 and cleaved poly(ADP-ribose) polymerase 1 were upregulated following RRM2 silencing compared with the control group. In addition, the results demonstrated that RRM2 silencing may inhibit target gene expression in the Wnt/beta-catenin signaling pathway by increasing the phosphorylation of glucose synthase kinase 3 beta. These findings indicated that RRM2 may be involved in the proliferation and apoptosis of MM cells via the Wnt/beta-catenin signaling pathway, suggesting that RRM2 may represent a novel therapeutic target for MM.
引用
收藏
页码:2159 / 2166
页数:8
相关论文
共 50 条
  • [21] Genetic determinants of multiple myeloma risk within the Wnt/ beta-catenin signaling pathway
    Belachew, Alem A.
    Wu, Xifeng
    Callender, Rashida
    Waller, Rosalie
    Orlowski, Robert Z.
    Vachon, Celine M.
    Camp, Nicola J.
    Ziv, Elad
    Hildebrandt, Michelle A. T.
    CANCER EPIDEMIOLOGY, 2021, 73
  • [22] IL-35 inhibits adipogenesis via PPARγ-Wnt/β-catenin signaling pathway by targeting Axin2
    Li, Yuxuan
    Yao, Lutian
    Lu, Jing
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 122
  • [23] Resveratrol inhibits proliferation, migration and invasion of multiple myeloma cells via NEAT1-mediated Wnt/β-catenin signaling pathway
    Geng, Weizheng
    Guo, Xin
    Zhang, Lirong
    Ma, Yiming
    Wang, Lei
    Liu, Zhen
    Ji, Hong
    Xiong, Ying
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 107 : 484 - 494
  • [24] Targeting the Wnt/β-Catenin Signaling Pathway and CD44-Mediated Adhesion As a Rational Approach to Overcome Lenalidomide Resistance in Multiple Myeloma
    Bjorklund, Chad C.
    Aukerman, Sharon Lea
    Lopez-Girona, Antonia
    Hussein, Mohamad
    Chopra, Rajesh
    Kuiatse, Isere
    Kuhn, Deborah J.
    Wei, Caimiao
    Orlowski, Robert Z.
    BLOOD, 2011, 118 (21) : 422 - 422
  • [25] RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS/STING signaling pathway in lung adenocarcinoma
    Xueping Jiang
    Yangyi Li
    Nannan Zhang
    Yanping Gao
    Linzhi Han
    Shuying Li
    Jiali Li
    Xingyu Liu
    Yan Gong
    Conghua Xie
    Cell & Bioscience, 11
  • [26] Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma
    Chim, C. S.
    Pang, R.
    Fung, T. K.
    Choi, C. L.
    Liang, R.
    LEUKEMIA, 2007, 21 (12) : 2527 - 2536
  • [27] RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS/STING signaling pathway in lung adenocarcinoma
    Jiang, Xueping
    Li, Yangyi
    Zhang, Nannan
    Gao, Yanping
    Han, Linzhi
    Li, Shuying
    Li, Jiali
    Liu, Xingyu
    Gong, Yan
    Xie, Conghua
    CELL AND BIOSCIENCE, 2021, 11 (01):
  • [28] Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma
    C S Chim
    R Pang
    T K Fung
    C L Choi
    R Liang
    Leukemia, 2007, 21 : 2527 - 2536
  • [29] Epigenetic dysregulation of WNT signaling pathway in multiple myeloma
    Chim, C. S.
    Fung, T. K.
    Pang, R.
    Choi, C. L.
    Liang, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 114 - 114
  • [30] RRM2-mediated Wnt/β-catenin signaling pathway activation in lung adenocarcinoma: A potential prognostic biomarker
    Jiang, Yongjie
    Hu, Xing
    Pang, Min
    Huang, Yuyan
    Ren, Bi
    He, Liping
    Jiang, Li
    ONCOLOGY LETTERS, 2023, 26 (04)